LymeNet Home LymeNet Home Page LymeNet Flash Discussion LymeNet Support Group Database LymeNet Literature Library LymeNet Legal Resources LymeNet Medical & Scientific Abstract Database LymeNet Newsletter Home Page LymeNet Recommended Books LymeNet Tick Pictures Search The LymeNet Site LymeNet Links LymeNet Frequently Asked Questions About The Lyme Disease Network LymeNet Menu

LymeNet on Facebook

LymeNet on Twitter




The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

LymeNet Flash Discussion
Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive


The Lyme Disease Network is a non-profit organization funded by individual donations.

LymeNet Flash Post New Topic  New Poll  Post A Reply
my profile | directory login | register | search | faq | forum home

  next oldest topic   next newest topic
» LymeNet Flash » Questions and Discussion » Medical Questions » Histamine receptors...Claritin H1R antagonist may not be enough

 - UBBFriend: Email this page to someone!    
Author Topic: Histamine receptors...Claritin H1R antagonist may not be enough
Marnie
Frequent Contributor (5K+ posts)
Member # 773

Icon 1 posted      Profile for Marnie     Send New Private Message       Edit/Delete Post   Reply With Quote 
Histamine H1- and H4-receptor signaling ***cooperatively regulate*** MAPK activation

http://www.sciencedirect.com/science/article/pii/S0006295215006218

MAPK =

Mitogen-activated protein kinases (MAPK) are protein kinases that are specific to the amino acids serine, threonine, and tyrosine. MAPKs belong to the CMGC (CDK/MAPK/GSK3/CLK) kinase group.

MAPKs are involved in directing cellular responses to a diverse array of stimuli, such as mitogens, osmotic stress, heat shock and proinflammatory cytokines.

They regulate cell functions including proliferation, gene expression, differentiation, mitosis, cell survival, and apoptosis (me = cell death).

Wikipedia


Look closely at H4R and Th17 cells (memory)...and the implication in "autoimmune" MS:

http://webcache.googleusercontent.com/search?q=cache:QgTdO8XHriwJ:http://etheses.dur.ac.uk/10651/ 2014


Though...

The ***role of histamine in autoimmunity*** and malignant disease through the *H1R* is well documented...


http://webcache.googleusercontent.com/search?q=cache:dL4-iEh-T80J:http://benthamopen.com/contents/pdf/TOIJ/TOIJ-2-9.pdf

Which histamine receptor(s) do we need to antagonize -

H1R, H2R, H3R, or H4R?


Read last sentence here:

http://europepmc.org/articles/pmc4151522

BTW...berberine impacts Th17 cells.

Very strange...rantinidine (+ bismuth citrate) can eliminate all forms of Bb *in the GI track* (Rx called Tritec).

Rantinidine is a *H2R antagonist.*

We know spirochetes have been found in the brains of those with AD...and the "latest" treatment involves another histamine receptor antagonist...

*a H3R antagonist.*

Infection triggered AD or infection + genetic predisposition?

http://webcache.googleusercontent.com/search?q=cache:u0PnGiaQb_kJ:http://www.miklossy.ch/media/Bb_AlzheimerJAD.pdf

Too little BH4 available - also needed to process ammonia. Each turn of the folate cycle produces one molecule of BH4.

Read just intro paragraph here:

http://webcache.googleusercontent.com/search?q=cache:-FPFGOlkFqMJ:http://europepmc.org/articles/pmc1027905/pdf/jnnpsyc00123-0086.pdf


Lyme disease-causing borreliae profit specifically from the broadly conserved ***tick histamine release factor (tHRF)***, and from cysteine-rich glycoproteins represented by Salp15 from Ixodes scapularis and Iric-1 from Ixodes ricinus ticks which they recruit to their outer surface protein C (OspC).

PMID:26352137 2015

Me...B6 + CBS (enzyme) -> cysteine -> taurine (lowers cholesterol = autism symptoms) + glutathione + sulfate in the transsulfuration pathway to lower homocysteine versus the "remethylation" pathway to lower homocysteine.

CBS upregulation and our gene types:

http://webcache.googleusercontent.com/search?q=cache:xMgi-Ta414MJ:http://geneticgenie.org/all-mutations/


"Tick histamine release factor is critical for Ixodes scapularis engorgement ***and transmission*** of the lyme disease agent.

These findings suggest that blocking tHRF might offer a viable strategy to complement ongoing efforts to develop vaccines to block tick feeding and transmission of tick-borne pathogens."

PMID:21124826 2010

High histamine levels, whatever the cause, increase one's proneness to allergies.

http://webcache.googleusercontent.com/search?q=cache:78WwGeNAmHQJ:http://www.arltma.com/Articles/AllergyDoc.htm

= "multiple chemical sensitivities"?

Garth N...

http://www.researchgate.net/publication/235918074_Chronic_Bacterial_and_Viral_Infections_in_Neurodegenerative_and_Neurobehavioral_Diseases

Underlying genetic differences AND subsequent exposure to pathogens may impact outcome, IMO.

Just as some persons may have an adverse reaction to a vaccine if their genetic profile differs from "normal" - perhaps:

http://www.ncbi.nlm.nih.gov/pubmed/17895626

So much for vaccines not possibly triggering autism in susceptible persons...

[ 09-21-2015, 01:59 PM: Message edited by: Marnie ]

Posts: 9424 | From Sunshine State | Registered: Mar 2001  |  IP: Logged | Report this post to a Moderator
   

Quick Reply
Message:

HTML is not enabled.
UBB Code� is enabled.

Instant Graemlins
   


Post New Topic  New Poll  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | LymeNet home page | Privacy Statement

Powered by UBB.classic™ 6.7.3


The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA


| Flash Discussion | Support Groups | On-Line Library
Legal Resources | Medical Abstracts | Newsletter | Books
Pictures | Site Search | Links | Help/Questions
About LymeNet | Contact Us

© 1993-2020 The Lyme Disease Network of New Jersey, Inc.
All Rights Reserved.
Use of the LymeNet Site is subject to Terms and Conditions.